B. Schlechter

发表

Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer.

D. Neuberg, M. Hidalgo, B. Furie, 2019, JCI insight.

Benjamin L. Schlechter, B. Schlechter, 2022, Hematology/oncology clinics of North America.

Incidental pulmonary embolism in pancreatic ductal adenocarcinoma: Impact of tumor and AJCC stages at initial staging CT.

A. Moser, K. Mortelé, Benjamin L. Schlechter, 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

A Veteran Presenting With Altered Mental Status and Clonus.

Anthony C Breu, D. Rangachari, B. Schlechter, 2020, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

Durable Response to PD-1 Blockade in a Patient With Metastatic Pancreatic Undifferentiated Carcinoma With Osteoclast-Like Giant Cells.

T. Chapman, B. Schlechter, L. Hertan, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer.

Roger B. Davis, M. Hidalgo, L. Muthuswamy, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium

Donald E. Ingber, Geraldine A. Hamilton, Andries D. van der Meer, 2016, Biomedical microdevices.

Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma

J. Lacy, B. Wolpin, M. Morse, 2023, JAMA network open.

Lower-Limb Salvage in a Patient with Recalcitrant Venous Ulcerations

N. Weinzweig, H. Baraniewski, J. Schuler, 1997, Journal of reconstructive microsurgery.

Reconstruction of posterior trunk defects.

S. Ramasastry, B. Schlechter, M. Cohen, 1995, Clinics in plastic surgery.

Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence.

P. S. Larson, C. Rosenberg, R. A. Blanchard, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Omission of or Poor Response to Preoperative Chemoradiotherapy Impacts Radial Margin Positivity Rates in Locally Advanced Rectal Cancer

E. Messaris, Ana Sofia Ore, B. Schlechter, 2021, Diseases of the colon and rectum.

Oncotype DX testing does not affect clinical practice in stage IIa colon cancer

E. Messaris, Benjamin L. Schlechter, B. Allar, 2022, Medical Oncology.

Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues.

L. Cupples, J. Garber, P. S. Larson, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tract formation following percutaneous endoscopic gastrostomy in an animal model

J. Ponsky, J. Mellinger, I. Simon, 2007, Surgical Endoscopy.

Loss of heterozygosity in serial plasma DNA samples during follow‐up of women with breast cancer

P. S. Larson, E. Finnemore, C. Rosenberg, 2003, International journal of cancer.

CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer

P. S. Larson, C. Rosenberg, R. Pistey, 2008, BMC Cancer.

An update on radioimmunotherapy for lymphoma

R. Joyce, Benjamin L. Schlechter, Michelle S. Kim, 2013 .

LBA O-9 Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer

A. El-Khoueiry, S. O’Day, A. Tsimberidou, 2022, Annals of Oncology.

Recovery of dialysis-dependent acute kidney injury after cessation of oxaliplatin

Lea Borgi, B. Schlechter, P. Hanna, 2023, Journal of Onco-Nephrology.

Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial.

D. Neuberg, A. Khorana, J. Zwicker, 2020, Blood advances.

Would You Refer This Patient With Cancer to a Palliative Care Specialist?

E. Reynolds, M. Buss, Anjala Tess, 2019, Annals of Internal Medicine.

Would You Refer This Patient With Cancer to a Palliative Care Specialist?

E. Reynolds, M. Buss, B. Schlechter, 2019, Annals of Internal Medicine.

G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans

P. Enzinger, B. Wolpin, D. Rubinson, 2023, Journal for ImmunoTherapy of Cancer.

Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium

D. Ingber, A. Michelson, G. Hamilton, 2016, Biomedical Microdevices.

Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC).

H. Lenz, G. Schwartz, A. Bullock, 2023, Journal of Clinical Oncology.